Patents Assigned to Institut De Recherches Cliniques De Montreal/ I.R.C.M.
  • Negative regulation of NK cell functions by EAT-2, a sap-related adaptor expressed in innate immune cells
    Publication number: 20100015654
    Abstract: The present invention relates to the identification EAT-2 and ERT as novel therapeutic targets for the modulation of innate immune cell functions. More particularly the present invention describes novel methods for modulating innate immune cells-mediated immune response, useful in the treatment of cancer, infectious diseases as well as autoimmune diseases.
    Type: Application
    Filed: May 15, 2006
    Publication date: January 21, 2010
    Applicant: Institut De Recherches Cliniques De Montreal/ I.R.C.M.
    Inventors: Andre Veillette, Romain Roncagalli